Dx Focus: Vela Diagnostics' Sentosa KRAS Test | GenomeWeb

Vela Diagnostics said this week that its Sentosa SA KRAS PCR Test is now available as a CE-IVD product.

The new test qualitatively assesses mutation status in DNA extracted from colorectal formalin-fixed paraffin-embedded tissues. It detects and differentiates seven mutations (G12A, G12C, G12D, G13D, G12R, G12S and G12V) in codons 12 and 13, which covers more than 97 percent of the known mutations in the KRAS gene.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Science this week: Neanderthal-derived DNA linked to modern ailments, and more.

Japan needs to catch up on its gene-editing research efforts, the Japan News writes.

Hundreds of people have signed an online petition calling for zero tolerance to sexual harassment in the sciences.

Jeff Huber, former Google X senior vice president, joins Grail as its CEO.